Christopher Pasquale
Stock Analyst at Barclays
(4.42)
# 1,236
Out of 5,162 analysts
189
Total ratings
62.5%
Success rate
10.6%
Average return
Main Sectors:
Stocks Rated by Christopher Pasquale
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLCO Bausch + Lomb | Reiterated: Buy | $24 → $27 | $20.69 | +30.50% | 2 | Nov 17, 2026 | |
| AVR Anteris Technologies Global | Reiterated: Hold | $10 → $9 | $5.09 | +76.82% | 3 | Nov 13, 2026 | |
| MMED MiniMed Group | Reiterated: Hold | $22 → $20 | $16.26 | +23.00% | 2 | Nov 13, 2026 | |
| SWX: ALC Alcon Inc. | Reiterated: Hold | CHF 58.47 → CHF 66.82 | CHF 63.32 | +5.53% | 4 | Nov 11, 2026 | |
| HUMA Humacyte | Reiterated: Hold | $0.5 → $0.6 | $0.5425 | +10.60% | 3 | Nov 11, 2026 | |
| BDX Becton, Dickinson and Company | Reiterated: Sell | $195 | $212.68 | -8.31% | 5 | Nov 10, 2026 | |
| BAX Baxter International | Reiterated: Sell | $20 → $23 | $25.39 | -9.41% | 7 | Nov 9, 2026 | |
| LIVN LivaNova | Reiterated: Buy | $105 → $120 | $92.07 | +30.34% | 3 | Nov 9, 2026 | |
| SENS Senseonics Holdings | Reiterated: Hold | $10 → $11 | $8.91 | +23.53% | 6 | Nov 9, 2026 | |
| TMDX TransMedics Group | Reiterated: Buy | $120 | $94.02 | +27.63% | 2 | Nov 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $100 → $115 | $101.47 | +13.33% | 14 | Nov 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $150 → $165 | $137.23 | +20.24% | 10 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $20 | $16.80 | +19.05% | 7 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $120 | $103.88 | +15.52% | 10 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $25.75 | +16.50% | 6 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $65 → $62 | $56.28 | +10.16% | 8 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $48 → $45 | $42.99 | +4.68% | 17 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $120 | $80.19 | +49.64% | 13 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $375 → $365 | $313.08 | +16.58% | 15 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $60 | $56.35 | +6.48% | 6 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $13.32 | +125.23% | 2 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $95 | $81.89 | +16.01% | 3 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $60 | $60.33 | -0.55% | 8 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $103.87 | +15.53% | 14 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $485 → $500 | $407.24 | +22.78% | 2 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $120 → $95 | $100.61 | -5.58% | 5 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $305 | $320.01 | n/a | 2 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.000001 | n/a | 4 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $25.94 | n/a | 1 | Nov 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $85 | $25.99 | n/a | 4 | Nov 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $80 | $13.55 | n/a | 1 | Jul 31, 2015 |
Bausch + Lomb
Nov 17, 2026
Reiterated: Buy
Price Target: $24 → $27
Current: $20.69
Upside: +30.50%
Anteris Technologies Global
Nov 13, 2026
Reiterated: Hold
Price Target: $10 → $9
Current: $5.09
Upside: +76.82%
MiniMed Group
Nov 13, 2026
Reiterated: Hold
Price Target: $22 → $20
Current: $16.26
Upside: +23.00%
Alcon Inc.
Nov 11, 2026
Reiterated: Hold
Price Target: CHF 58.47 → CHF 66.82
Current: CHF 63.32
Upside: +5.53%
Humacyte
Nov 11, 2026
Reiterated: Hold
Price Target: $0.5 → $0.6
Current: $0.5425
Upside: +10.60%
Becton, Dickinson and Company
Nov 10, 2026
Reiterated: Sell
Price Target: $195
Current: $212.68
Upside: -8.31%
Baxter International
Nov 9, 2026
Reiterated: Sell
Price Target: $20 → $23
Current: $25.39
Upside: -9.41%
LivaNova
Nov 9, 2026
Reiterated: Buy
Price Target: $105 → $120
Current: $92.07
Upside: +30.34%
Senseonics Holdings
Nov 9, 2026
Reiterated: Hold
Price Target: $10 → $11
Current: $8.91
Upside: +23.53%
TransMedics Group
Nov 9, 2026
Reiterated: Buy
Price Target: $120
Current: $94.02
Upside: +27.63%
Nov 9, 2026
Reiterated: Hold
Price Target: $100 → $115
Current: $101.47
Upside: +13.33%
Nov 6, 2026
Reiterated: Hold
Price Target: $150 → $165
Current: $137.23
Upside: +20.24%
Nov 6, 2026
Reiterated: Hold
Price Target: $18 → $20
Current: $16.80
Upside: +19.05%
Nov 5, 2026
Reiterated: Buy
Price Target: $110 → $120
Current: $103.88
Upside: +15.52%
Nov 5, 2026
Reiterated: Buy
Price Target: $30
Current: $25.75
Upside: +16.50%
Nov 3, 2026
Reiterated: Sell
Price Target: $65 → $62
Current: $56.28
Upside: +10.16%
Oct 30, 2026
Reiterated: Hold
Price Target: $48 → $45
Current: $42.99
Upside: +4.68%
Oct 30, 2026
Reiterated: Buy
Price Target: $115 → $120
Current: $80.19
Upside: +49.64%
Oct 30, 2026
Reiterated: Buy
Price Target: $375 → $365
Current: $313.08
Upside: +16.58%
Oct 29, 2026
Reiterated: Buy
Price Target: $50 → $60
Current: $56.35
Upside: +6.48%
Oct 29, 2026
Reiterated: Buy
Price Target: $30
Current: $13.32
Upside: +125.23%
Oct 29, 2026
Reiterated: Buy
Price Target: $85 → $95
Current: $81.89
Upside: +16.01%
Oct 28, 2026
Reiterated: Hold
Price Target: $60
Current: $60.33
Upside: -0.55%
Oct 22, 2026
Reiterated: Buy
Price Target: $120
Current: $103.87
Upside: +15.53%
Oct 21, 2026
Reiterated: Buy
Price Target: $485 → $500
Current: $407.24
Upside: +22.78%
Oct 6, 2026
Initiated Coverage: Hold
Price Target: $120 → $95
Current: $100.61
Upside: -5.58%
Jul 30, 2025
Upgraded: Buy
Price Target: $305
Current: $320.01
Upside: n/a
May 7, 2021
Upgraded: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Nov 6, 2019
Reiterated: Buy
Price Target: $150
Current: $25.94
Upside: n/a
Nov 5, 2018
Reiterated: Buy
Price Target: $57 → $85
Current: $25.99
Upside: n/a
Jul 31, 2015
Upgraded: Buy
Price Target: $80
Current: $13.55
Upside: n/a